CONTROVERSIES IN ANTIPLATELET AND ANTICOAGULANT THERAPY

被引:0
|
作者
Bhatt, D. L. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
363
引用
收藏
页码:376 / 376
页数:1
相关论文
共 50 条
  • [41] Pharmacogenetic considerations in therapy with novel antiplatelet and anticoagulant agents
    Yazbeck, Anthony
    Akika, Reem
    Awada, Zainab
    Zgheib, Nathalie K.
    PHARMACOGENETICS AND GENOMICS, 2024, 34 (03): : 61 - 72
  • [42] ANTIPLATELET AND ANTICOAGULANT-THERAPY DURING CORONARY THROMBOLYSIS
    FITZGERALD, DJ
    FITZGERALD, GA
    TRENDS IN CARDIOVASCULAR MEDICINE, 1991, 1 (01) : 29 - 35
  • [43] Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
    Brunetti, Natale Daniele
    De Gennaro, Luisa
    Di Biase, Matteo
    Caldarola, Pasquale
    IJC HEART & VASCULATURE, 2019, 24
  • [44] Concomitant antiplatelet and anticoagulation therapy: Indications, controversies and practical advice
    Dowd, M.
    THROMBOSIS RESEARCH, 2008, 123 : S11 - S15
  • [45] Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention
    Weber, Ralph
    Diener, Hans-Christoph
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (10) : 2371 - 2380
  • [46] Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges
    Serebruany, Victor L.
    Cherepanov, Vasily
    Cabrera-Fuentes, Hector A.
    Kim, Moo Hyun
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (06) : 1104 - 1112
  • [47] Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience
    Effron, Mark B.
    Gibson, C. Michael
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 531 - 536
  • [48] Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
    Chi-Juei Jeng
    Yi-Ting Hsieh
    Cheng-Li Lin
    I-Jong Wang
    BMC Ophthalmology, 22
  • [49] USE OF SUBCUTANEOUS IMMUNOGLOBULIN IN PATIENTS ON CONCOMITANT ANTICOAGULANT AND ANTIPLATELET THERAPY
    Stein, M. R.
    Farnan, K.
    Eufrasio, D.
    Duff, C.
    Hunter, J.
    Ochoa, D.
    Levasseur, M. -C.
    Aro, L.
    Zampelli, A.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 347 - 348
  • [50] Antiplatelet and anticoagulant therapy in elderly people with diabetes mellitus in Poland
    Labuz-Roszak, B.
    Pierzchala, K.
    Machowska-Majchrzak, A.
    Skrzypek, M.
    Mossakowska, M.
    Chudek, J.
    Wiecek, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 604 - 604